Enfermedades endocrinas asociadas a vacunación por la COVID-19: reporte de casos

Alberto A. Teruya-Gibu; Percy Ortiz-Guerra; Abad A. Arzapalo-Poma

doi:10.17843/rpmesp.2023.403.12572

Authors

Alberto A. Teruya-Gibu Servicio de Endocrinología, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú https://orcid.org/0000-0003-3816-4011
Percy Ortiz-Guerra Servicio de Banco de Órganos y Laboratorio de Histocompatibilidad, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú https://orcid.org/0000-0003-4641-6127
Abad A. Arzapalo-Poma Servicio de Banco de Órganos y Laboratorio de Histocompatibilidad, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú https://orcid.org/0000-0002-2325-1748

DOI:

https://doi.org/10.17843/rpmesp.2023.403.12572

Keywords:

Subacute Thyroiditis, Autoimmune Hypoglycemia, COVID-19, Vaccination

Abstract

SARS-CoV-2 vaccination is not free of adverse effects. We present two cases of endocrine involvement associated with COVID-19 vaccination. A 46-year-old woman who, after receiving the first COVID-19 vaccination dose, presented persistent fever and signs of thyrotoxicosis after being diagnosed with subacute thyroiditis associated with COVID-19 vaccination; the condition remitted with the use of corticoids. A 71-year-old male, who after COVID-19 vaccination, presented hyperinsulinemic hypoglycemia, testing positive for anti-insulin antibodies; he was diagnosed with autoimmune hypoglycemia associated with
COVID-19 vaccination and received treatment with prednisone, controlling the episodes of hypoglycemia.
In conclusion, endocrine diseases associated with COVID-19 vaccination are extremely rare and their timely detection allows adequate treatment.

Downloads

Download data is not yet available.

References

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7.

Centro Nacional de Epidemiología, Prevención y Control de Enfermedades. Brote de nuevo coronavirus (COVID-19) [Internet].

Lima: Ministerio de Salud; 2020 [citado el 9 de enero de 2022]. Disponible en: https://www.dge.gob.pe/portal/docs/tools/coronavirus/coronavirus060320.pdf.

Organización Mundial de la Salud. Coronavirus disease 2019 (COVID-19) Situation Report – 51[Internet]. Ginebra: OMS; 2020

[citado el 9 de enero de 2022]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/331475/nCoVsitrep11Mar2020-eng.pdf?sequence=1&isAllowed=y.

Decreto Supremo N° 008-2020-SA, Lima, 11 de Marzo de 2020. [citado el 9 de enero de 2022]. Disponible en: https://cdn.www.gob.pe/uploads/document/file/605928/DS_008-2020-SA.PDF.

Ministerio de Salud del Perú. Vacuna COVID-19 en el Perú [Internet]. Lima: MINSA; 2023 [citado el 24 de mayo del 2023]. Disponible en: https://www.minsa.gob.pe/reunis/data/vacunas-covid19.asp.

Asghar N, Mumtaz H, Syed AA, Eqbal F, Maharjan R, Bamboria A, et al. Safety, efficacy, and immunogenicity of COVID-19 vaccines;

a systematic review. Immunol Med. 2022;45(4):225-237. doi: 10.1080/25785826.2022.2068331.

Zhao Y, Wu X. Influence of COVID-19 vaccines on endocrine system. Endocrine. 2022;78(2):241-246. doi: 10.1007/s12020-022-03119-3.

Pezzaioli LC, Gatta E, Bambini F, Facondo P, Gava M, Cavadini M, et al. Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature. Front Endocrinol (Lausanne). 2022;13:1027047. doi: 10.3389/fendo.2022.1027047.

Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A. The Association of Subacute Thyroiditis with COVID-19: a Systematic Review. SN Compr Clin Med. 2021;3(7):1515-1527. doi: 10.1007/s42399-021-00912-5.

Ratnayake GM, Dworakowska D, Grossman AB. Can COVID-19 immunisation cause subacute thyroiditis? Clin Endocrinol (Oxf).

;97(1):140-141. doi: 10.1111/cen.14555.

İremli BG, Şendur SN, Ünlütürk U. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome. J Clin Endocrinol Metab. 2021;106(9):2600-2605. doi: 10.1210/clinem/dgab373.

Franquemont S, Galvez J. Subacute Thyroiditis After mRNA Vaccine for Covid-19. J Endocr Soc. 2021;5(Suppl 1):A956–7. doi: 10.1210/jendso/bvab048.1954.

Ohsako N, Tamai H, Sudo T, Mukuta T, Tanaka H, Kuma K, et al. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. 1995;80(12):3653-6. doi: 10.1210/jcem.80.12.8530615.

Stasiak M, Tymoniuk B, Adamczewski Z, Stasiak B, Lewiński A. Sonographic Pattern of Subacute Thyroiditis Is HLA-Dependent. Front

Endocrinol (Lausanne). 2019;10:3. doi: 10.3389/fendo.2019.00003.

Şendur SN, Özmen F, Oğuz SH, İremli BG, Malkan ÜY, Gürlek A, et al. Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis. Thyroid. 2022;32(6):640-647. doi: 10.1089/thy.2022.0010.

Wall JR, Fang SL, Ingbar SH, Braverman LE. Lymphocyte transformation in response to human thyroid extract in patients with subacute thyroiditis. J Clin Endocrinol Metab. 1976;43(3):587-90. doi: 10.1210/jcem-43-3-587.

Kobayashi N, Tamai H, Nagai K, Matsubayashi S, Matsuzuka F, Kuma K, et al. [Studies on the pathogenesis of subacute thyroiditis].

Nihon Naibunpi Gakkai Zasshi. 1985 20;61(7):737-43. Japanese. doi: 10.1507/endocrine1927.61.7_737.

Ray I, D’Souza B, Sarker P, Agarwal P. Management of Subacute Thyroiditis - A Systematic Review of Current Treatment Protocols. Int J Gen Med. 2022;15:6425-6439. doi: 10.2147/IJGM.S366784.

Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28. doi: 10.1210/jc.2008-1410.

Uchigata Y, Hirata Y, Omori Y. A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata’s disease). Autoimmunity. 1995;20(3):207-8. doi: 10.3109/08916939508993352.

Oest L, Roden M, Müssig K. Comparison of patient characteristics between East Asian and non-East Asian patients with insulin autoimmune syndrome. Clin Endocrinol (Oxf). 2022;96(3):328-338. doi: 10.1111/cen.14634.

Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792. doi: 10.1016/j.autrev.2021.102792.

Cappellani D, Macchia E, Falorni A, Marchetti P. Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description. Diabetes Metab Syndr Obes. 2020;13:963-978. doi: 10.2147/DMSO.S219438.

van Drongelen V, Holoshitz J. Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis. Rheum Dis Clin North Am.

;43(3):363-376. doi: 10.1016/j.rdc.2017.04.003.

Kraus AU, Penna-Martinez M, Shoghi F, Seidl C, Meyer G, Badenhoop K. HLA-DQB1 Position 57 Defines Susceptibility to Isolated and

Polyglandular Autoimmunity in Adults: Interaction With Gender. J Clin Endocrinol Metab. 2019;104(6):1907-1916. doi: 10.1210/jc.2018-01621.